Abnormal uterine bleeding: Medical treatment with vaginal danazol and five-year follow-up

Journal of the American Association of Gynecologic Laparoscopists

Volumn 11, Issue 3, 2004, Pages 340-343

  Mais, Valerio ^a   Cossu, Ester ^a   Angioni, Stefano ^a   Piras, Bruno ^a   Floris, Lucia ^a   Melis, Gian B ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HOT FLUSH; HUMAN; PREGNANCY RATE; SLEEP DISORDER; UTERUS BLEEDING; VAGINA DISEASE; WEIGHT GAIN;

EID: 4444341582     PISSN: 10743804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-3804(05)60047-3     Document Type: Article

References (14)

1. Chuong CJ, Brenner PF: Management of abnormal uterine bleeding. Am J Obstet Gynecol 1996, 175:787-92.
2. Lindahl B, Alm P, Ferno M, et al: Endometrial hyperplasia: A prospective randomized study of histopathology, tissue steroid receptors, and plasma steroids after abrasio, with or without high dose gestagen treatment. Anticancer Res 1990, 10:725-30.
3. Lindahl B, Willen R: Spontaneous endometrial hyperplasia. A 5-year follow-up of 82 patients after high-dose gestagen treatment. Anticancer Res 1994, 14:2831-4.
4. Chimbira TH, Anderson AB, Naish C, et al: Reduction of menstrual blood loss by danazol in unexplained menorrhagia: Lack of effect of placebo. Br J Obstet Gynaecol 1980, 87:1152-8.
5. Dockeray CJ, Sheppard BL, Bonnar J: Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. Br J Obstet Gynaecol 1989, 96:840-4.
6. Higham JM, Shaw RW: A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am J Obstet Gynecol 1993, 169:1134-9.
7. Soh E, Sato K: Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women. Cancer 1990, 66:983-8.
8. Beaumont H, Augood C, Duckitt K, et al: Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2002. 2:CD001017.
9. The Nafarelin European Endometriosis Trial Group (NEET): Nafarelin for endometriosis: A large scale, danazol-controlled trial of efficacy and safety, with 1-year follow up. Fertil Steril 1992, 57:514-22.
10. Guerriero S, Paoletti AM, Ajossa S, et al: Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy. Menopause 2001, 8:424-8.
11. Kim YB, Holschneider CH, Ghosh K, et al: Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: Report of seven cases and review of the literature. Cancer 1997, 79:320-7.
12. Kaku T, Yoshikawa H, Tsuda H, et al: Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: Central pathologic review and treatment outcome. Cancer Lett 2001, 167:39-48.
13. Goker EN, Sendag F, Tavmergen E, et al: Successful pregnancy in an infertile woman with endometrial hyperplasia and embryo transfer: A case report. J Reprod Med 2001, 46:859-62.
14. Cooper KG, Jack SA, Parkin DE, et al: Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes. BJOG 2001, 108:1222-8.